HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 865-876 of 4,505
Other study type icon
CompletedNCT00119574

Evaluating a Collaborative Care Model for Schizophrenia (EQUIP)

Official study title

Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)

This study has finished and is no longer accepting participants.

In West Los Angeles
SchizophreniaInterventional studyAges 18+
Countries
United States
Sponsor
US Department of Veterans Affairs
Other study type icon
TerminatedNCT00001198

Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia

Official study title

Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients

This study ended early.

In Bethesda
SchizophreniaObservational studyAges 6+
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedNCT00412373

Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in people with Schizoaffective Disorder.

Official study title

A Randomized, Double-blind, Placebo-controlled, Parallel- Group Study to Evaluate the Efficacy and Safety of Flexible-dose Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
SchizophreniaMedication studyAges 18–65
Countries
United States, India, Malaysia, + 3 others
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug study icon
CompletedNCT00397033

Evaluation of Effectiveness and Safety of Paliperidone Extended Release in people with Schizoaffective Disorder.

Official study title

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Two Dosages of Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18–65
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Behavioral study icon
CompletedNCT02787122

-study of Emotion-focused Cognitive Behavior Therapy for people with Schizophrenia

Official study title

Comparison of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia With Standard Treatment: Effects on Psychological Parameters and Rehospitalisation

This study has finished and is no longer accepting participants.

Multiple locations, including Marburg
SchizophreniaBehavioural studyAges 18–70
Countries
Germany
Sponsor
Philipps University Marburg
Drug study icon
TerminatedNCT02949232

Prednisolone Addition for people with Recent-onset Psychotic Disorder

Official study title

Prednisolone Addition for Patients With Recent-onset Psychotic Disorder: the Role of Immune-modulating Strategies in the Treatment of Psychosis

This study ended early.

Multiple locations, including Antwerp
SchizophreniaMedication studyAges 18–70
Countries
Belgium, Denmark, Netherlands
Sponsor
UMC Utrecht
Drug study icon
CompletedNCT00929955

Role of Anti-Inflammatory Agents in people with Schizophrenia

Official study title

Study of Role of Anti-Inflammatory Agents in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Karachi
SchizophreniaMedication studyAges 18–65
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.